hVIVO Services Ltd, QMB Bioenterprise building
About hVIVO Services Ltd, QMB Bioenterprise building
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at hVIVO Services Ltd, QMB Bioenterprise building
During the past decade, hVIVO Services Ltd, QMB Bioenterprise building conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
2015-05-14
2017-03-27
Completed
275
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RA
2015-10-29
2017-06-02
Completed
65
A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes
2019-05-07
2021-03-31
Completed
636
Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)
2020-11-23
2022-02-01
Completed
500
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
2021-03-29
2023-04-10
Completed
938
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
2021-01-29
2023-10-17
Active, not recruiting
627
A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
2021-04-13
2023-04-29
Active, not recruiting
585
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "hVIVO Services Ltd, QMB Bioenterprise building"
#1 collaborator was "Hvivo" with 2 trials as a collaborator, "Prep Biopharm Limited" with 1 trials as a collaborator and "Royal Free Hospital NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at hVIVO Services Ltd, QMB Bioenterprise building
According to Clinical.Site data, the most researched conditions in "hVIVO Services Ltd, QMB Bioenterprise building" are
"Covid19" (2 trials), "COVID-19" (1 trials), "Corona Virus Infection" (1 trials), "Coronavirus" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "hVIVO Services Ltd, QMB Bioenterprise building" in a lesser frequency.
Clinical Trials Intervention Types at hVIVO Services Ltd, QMB Bioenterprise building
Most popular intervention types in "hVIVO Services Ltd, QMB Bioenterprise building" are "Biological" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "High Titre Influenza virus" (1 trials), "Low titre" (1 trials), "Medium - High Influenza virus" (1 trials), "Medium Low Titre Influenza virus" (1 trials) and "Placebo Comparator" (1 trials). Other intervention names were less common.
Clinical Trials Genders at hVIVO Services Ltd, QMB Bioenterprise building
The vast majority of trials in "hVIVO Services Ltd, QMB Bioenterprise building" are
4 trials for "All" genders.
Clinical Trials Status at hVIVO Services Ltd, QMB Bioenterprise building
Currently, there are NaN active trials in "hVIVO Services Ltd, QMB Bioenterprise building".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in hVIVO Services Ltd, QMB Bioenterprise building,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in hVIVO Services Ltd, QMB Bioenterprise building, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".